for some of the variability in these studies (London, 1984) . More recent studies of dementia using PET similarly have demonstrated declines in CBF, CMR0 2 , and CMRglu (Benson et a!. , 1983; de Leon et aI. , 1983; Foster et aI. , 1984) . However, PET studies have produced conflicting results in normal aging. Some investi gators have found age-related declines in CBF, CMR0 2 (Frackowiak et a!. , 1980; Frackowiak and Gibbs, 1983; Pantano et a!. , 1984) , and CMRglu (Kuhl et a!. , 1982) , while others have found CMRglu to be age invariant (de Leon et a!. , 1983; Duara et a!. , 1984) .
Both normal aging and senile dementia of the Alz heimer type (SDAT) are associated with brain atrophy (Gado et al. , 1982; Zatz et al. , 1982; Damasio et a!. , 1983; de Leon et a!. , 1983; Schwartz et a!. , 1985) . Measurements of CBF, CMR0 2 , and CMRglu using earlier nontomographic methods, such as the Kety -Schmidt technique (1948) , are not affected by brain atrophy because these methods record data only per unit of extant tissue. To mographic techniques such as PET, on the other hand, provide physiologic measurements per unit volume of intracranial contents. Thus, global PET data, averaged over one or more tomographic slices, will be affected by the inclusion of metabol ically inactive CSF spaces in the volume over which the PET measurement is averaged. Data equivalent to those given by the Kety-Schmidt technique can be obtained only by explicitly correcting PET mea surements for the presence of CSF spaces, or by selecting regions of interest such that partial volume averaging with ventricular or sulcal spaces is avoided, an approach difficult to implement be cause of the limited spatial resolution of PET. Given this problem, it is difficult to determine whether changes observed in PET measurements in normal aging and dementia are due to changes in brain he modynamics and metabolism, brain atrophy, or a combination of the two. In this study, we describe a strategy to correct global PET measurements for the effects of cerebral atrophy by integrating data from both quantitative computed tomography (CT) scans and PET scans. We illustrate its application to data obtained in three groups: normal young, normal aged, and SDAT subjects. A preliminary re port of this approach has previously appeared (Hers covitch et aI. , 1983b) .
MATERIALS AND METHODS
Three groups of subjects were studied: 10 normal young subjects [mean age 27.5 ± 3.6 (SD) years, range 22-34 years], 8 normal aged subjects (mean age 72.8 ± 5.2 years, range 68-84 years), and 6 SDAT subjects (mean age 75.3 ± 2.6 years, range 71-79 years). The young group consisted of healthy volunteers who were without known neurological, psychiatric, or chronic med ical diseases. Normal aged and SDAT subjects were en rolled in the Memory and Aging Project at Washington University Medical Center (Berg et a!., 1982). Normal aged subjects were without evidence of neurological, psy chiatric, or chronic medical diseases by history, physical examination, laboratory studies, and head CT except for the presence of atrophy. In addition, they all had a score of 0 (healthy) on the clinical dementia rating (CDR) scale (Berg et a!., 1982; Hughes et aI., 1982) . All SDAT subjects exhibited gradual onset and progression of global intel lectual deterioration for ;;.6 months and had CDR scores of I (mild dementia). Other causes of the dementia syn drome were specifically excluded by history, physical ex amination, laboratory studies, and head CT. The SDAT patients were also without evidence of other neurological, psychiatric, or chronic medical diseases.
PET was performed using the PETT VI system (Ter Pogossian et a!., 1982; Yamamoto et aI., 1982) . This ma chine collects seven contiguous tomographic slices with a center-to-center separation of 14.4 mm and a transverse resolution of 12.4-14.0 mm. Each subject received a single intravenous bolus injection of H2150, and briefly inhaled air containing trace amounts of Cl50 and 0150. Scan data obtained following the administration of each tracer were used to calculate CBF, cerebral blood volume (CBV), and CMR02• The mathematical models that un derlie these measurements and details of their implemen tation with the PETT VI system have been previously described (Grubb et aI., 1978; Herscovitch et aI., 1983a; Raichle et a!., 1983; Mintun et aI., 1984) . At the time of each study, a lateral skull radiograph was obtained with the center of each PET slice marked by a radiopaque wire (Fox et aI., 1985) . This record of the PET slices in relation to the bony landmarks of the skull was subsequently used to obtain CT slices encompassing the same brain regions. A tomographic transmission scan using a ring source of activity containing 68Ge/68Ga was performed in each sub ject to determine the attenuation characteristics of the head. All scans were done with the patient in the resting state; room lights were dimmed, and ambient noise was primarily from cooling fans for the electronic equipment. Oxygen content and carbon dioxide tension were mea sured on samples of arterial blood drawn from an in dwelling arterial cannula during each PET study.
Global average values for each SUbject's CBF, CMRO" and CBV were obtained from four contiguous suprate ntorial PET slices. The intracranial dimensions were defined by a threshold routine applied to each sub ject's attenuation scan. The outer table of the skull was determined by removing from the periphery of the atten uation image all pixels having values <80% of the max imum photon attenuation value for that slice. An addi tional two pixels (5.4 mm) were circumferentially re moved from the border of the 80% thresholded attenuation image to define the inner table. This method has previously been shown to correlate with intracranial dimensions in normal subjects (Fox et a!., 1985) . The in tracranial dimensions thus defined were then used as a template for that SUbject's CBF, CMROe, and CBV images. Global values were then calculated by averaging data from the four PET slices. These global values were thus derived from an intracranial volume that contains both metabolically active brain tissue and metabolically inactive CSF spaces.
CT scans were performed on Siemans Somatom II scanners. Contiguous CT slices 8 mm thick were ob tained. A CT-generated digital radiogram (Topogram) provided a lateral view of the skull in the CT gantry. This was used in conjunction with the lateral radiograph ob tained at the time of PET, to angulate the CT scanner gantry and obtain CT slices parallel to and encompassing the same brain regions as the PET slices. Volumetric measurements of CSF spaces (ventricles plus sulci) were generated from the seven adjacent supratentorial slices (total thickness 56 mm) corresponding to the four PET slices (total thickness 57.6 mm). The volumes that were studied included the lateral and third ventricles and the central white matter. They excluded the highest sections, which might contain partial volume artifacts caused by the curve of the calvaria, and the lowest ones, containing the posterior fossa as well as artifacts caused by the base of the skull and air spaces (Gado et aI., 1982) . The volume of ventricles and sulci was expressed as a percentage of intracranial volume, i.e., (V+S)%, by calculating the number of pixels of CSF density and dividing by the total number of intracranial pixels in the slices (Gado et aI., 1982) . The (V + S)% measurements were used to individ ually correct PET measurements for variability in amount of brain atrophy (see below). Individual measurements of (V + S)% were obtained for each normal aged subject and each SDAT subject. The young normal subjects did not receive individual quantitative CT examinations. Instead, we used the average value of (V + S)% determined by the quantitative CT study of an equal number (n = 10) of age-matched [mean age 28.6 ± 2.3 (SD) years, range 25-33 years] patients who had received CT scans as part of a clinical evaluation for various medical complaints [headache (six), depression (two), facial trauma (one), and parasthesias (one)]. They were selected from se quential CT examinations at our institution on the basis of age, a normal neurological exam, and a CT scan reading that, excluding assessment of CSF spaces, was normal.
To accurately compare the CBF, CMROz, and CBV per unit brain tissue in the normal young, normal aged, and SDAT states, it is necessary to correct the global PET values calculated as described above for the amount of cerebral atrophy encountered in each subject (Herscov itch et aI., 1983b). We accomplished this by dividing the calculated global values of CBF, CMROo, and CBV for each subject by the fraction of their intr a cranial volume actually occupied by brain tissue. This fraction is equal to 1 -0.01 x (V + S)% for each subject.
Comparisons among the three groups were tested for significance with analysis of variance and the Neuman Keuls multiple-range test using an experimentwise ct level of 0.05. Because seven separate measurements [age, PC02, O2 content, (V + S)%, CBF, CMR02, CBV] were made, an ct level of 0.0071 was used for each of the seven analyses to compensate for the effect of multiple com parisons. All grouped data are expressed as the mean and 1 SD.
RESULTS
The normal aged group and the SDAT group did not differ significantly in age, whereas both differed significantly from the young normals. None of the groups differed significantly from one another in ar terial PCOz or in arterial Oz content. Significant dif ferences existed among all three groups in the volume of CSF spaces (Table 1) .
Mean uncorrected and corrected global values for CBF, CMROz, and CBV appear in Ta ble 2. The un corrected values show that SDAT subjects have a significantly lower global CBF than the normal young or normal aged subjects and a significantly lower CMROz than normal young subjects. Normal young subjects and normal aged subjects showed no significant differences in any of the three PET measurements. When these data are corrected for individual variations in (V + S)%, the depression in CBF in SDAT subjects was less marked in compar ison with normal subjects, and no difference was observed among the three groups in CMR0 2 •
DISCUSSION
PET differs from earlier non tomographic tech niques of measuring CBF and metabolism, such as the Kety-Schmidt method, in that it provides mea surements per unit of volume of intracranial con tents. Thus, metabolically inactive CSF spaces may be included in the volume in which the PET mea surement is made. As observed in this study, and as has been described by others (Gado et aI. , 1982; Zatz et aI. , 1982; Damasio et aI. , 1983; de Leon et aI. , 1983; Schwartz et aI. , 1985) , there is an increase in the size of the CSF spaces in normal aging and, to a greater extent, in SDAT. This could result in an artifactual lowering of global PET measurements of CBF and metabolism in aging and SDAT.
We have described a method to correct such global PET measurements for the effect of cerebral atrophy. When this strategy was applied to global PET data obtained in normal young, normal aged, and SDAT subjects, the corrected data led to ob servations different from those obtained from the uncorrected measurements. Thus, corrected CBF in SDAT patients was less depressed in comparison with normal subjects than was the uncorrected CBF. The decrease that was seen in uncorrected CMROz in SDAT did not reach statistical signifi cance when the data were corrected for cerebral atrophy. These findings demonstrate the impor tance of correcting global PET measurements for cerebral atrophy, especially in patient groups in which the size of the CSF spaces may vary. They indicate that a component of the decline in global CBF and metabolism observed in PET studies of normal aging and dementia may be due to a lack of correction for cerebral atrophy. Certain investiga tors who measured both CBF and CMR0 2 in aging, however, have noted a steeper decline in one than the other, that is, either in CMR02 (Pantano et aI. , 1984) or in CBF (Frackowiak and Gibbs, 1983) , sug gesting a physiological process in addition to any methodological effects.
The finding that corrected CMR0 2 in the SDAT subjects was not significantly decreased should be interpreted with caution. First, our subjects had only mild dementia (CDR = I), whereas other studies included more severely affected patients (Frackowiak et aI. , 1981) . Second, the relatively small patient sample reduced our ability to detect statistically significant differences in the measure ments made, especially with the adjustment of level of statistical significance for multiple comparisons.
The strategy we used to correct global PET data for cerebral atrophy requires that both the PET and CSF space measurements be obtained from the same intracranial volume. It is not necessary, how ever, that there be a one-to-one correspondence be tween individual PET and CT slices, as these, in general, will have different slice thicknesses. We recorded the levels of our PET slices in relation to the bony landmarks of the skull on a lateral skull radiograph (Fox et aI. , 1985) . A similar lateral dig ital radiogram (Topogram) obtained with the subject in the CT gantry permitted selection of the CT angle and levels so that CT slices could be obtained to encompass the same intracranial volume as the PET slices. This procedure was performed in our normal aged and SDAT subjects, but not in the young nor mals. In these latter subjects, the CT and PET slices encompassed equivalent intracranial levels (i. e. , in cluding the lateral ventricles and central white matter), but differed somewhat in angulation. How ever, studies in which CT measurements were per formed at different angles in the same subjects have shown that the resulting variation in (V + S)% is <7% of the baseline value (M. Gado, unpublished results) .
We used a semiautomated technique to determine the size of the CSF spaces in relation to the intra cranial volume in contiguous CT slices (Gado et aI. , 1982) . Certain factors may limit the accuracy of this technique in determining CT pixels corresponding to CSF. These include the partial volume effect (Goodenough et aI. , 1982) , resulting in some pixels having attenuation intermediate between CSF and parenchyma; beam-hardening artifacts (Brooks and DiChiro, 1976) , increasing CT numbers near bone; and the selection of the CT density cutoff level used to identify pixels of CSF density. In spite of these potential problems, the technique has been validated in cadavers in which CT measure ments were found to be highly correlated with di rect, independent determinations of brain and CSF volumes (M. Gado et aI. , unpublished results ). An other potential difficulty is the occurrence, in some elderly and demented subjects, of areas of low white matter attenuation (Mori et aI. , 1980; Goto et aI. , 1981) , which could erroneously be included in the measurement of CSF volume. None of our sub jects, however, had such white matter lucencies. Finally, we note that our strategy for correcting global PET measurements for cerebral atrophy is compatible with other methods for estimating CSF space volume, using either CT (Zatz et aI. , 1982; Albert et aI. , 1984; Schwartz et aI. , 1985) or mag netic resonance images, provided the PET and an atomic measurements are obtained from equivalent intracranial volumes.
A major strength of PET is its ability to provide measurements on a regional basis. Such regional measurements may provide more insight into alter ations in CBF and metabolism associated with aging or dementia than global averages. In addition, mea surements obtained from mUltiple representative brain regions can be averaged to obtain an estimate of global values (Frackowiak et aI. , 1981; Pantano et aI. , 1984 ). Individual regional measurements may also be artifactual1y reduced, however, by contam ination with CSF spaces, for example, by partial volume averaging with a nearby sulcus or ventricle, or when part of the region itself consists of the CSF space. It should be possible to develop a strategy to correct regional PET measurements for these ef fects, using x-ray CT or magnetic resonance images obtained in the same plane as the PET slices.
In summary, we have described a method to cor rect global values of PET measurements for the per centage of the intracranial volume occupied by CSF. Such a correction is particularly required when PET is used to study conditions associated with significant degrees of cerebral atrophy, such as normal aging and SDAT.
